prophaselabs.com - PRPH Company Short-Term Debt

ProPhase Labs (PRPH) - corporate logo

ProPhase Labs, Inc. (PRPH) is optimizing biomaterial logistics through third-party operators to eliminate operational risks. Current borrowings on this GURU.Markets platform chart reflect repayment dynamics, where the 0.01 metric serves as the target level. Efficiency is sustained via the outsourcing of IT services and test production, while high market resilience is ensured by strict FDA control and a unique drug distribution network.

PRPH (ProPhase Labs) Company Short-Term Debts history from 07/04/2022 to 01/10/2026

ProPhase Labs Corp - analytical breakdowns and key metrics (PRPH)

- price and consensus price forecast:
Stock Price ProPhase Labs|PRPH - Analyst Consensus Forecast
- market capitalization data:
Market Value ProPhase Labs, Inc.|PRPH - Business Value
- book capitalization data:
Book Value per Share ProPhase Labs|PRPH - Book Capitalization|Market Value to Book Value Ratio prophaselabs.com|PRPH - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio ProPhase Labs, Inc.|PRPH - Long-Term Liabilities to Capital|Short-Term Debt to Equity ProPhase Labs, Inc.|PRPH - Company Total Debt Obligations|Debts to Book Capitalization ProPhase Labs, Inc.|PRPH - Long-Term Debt Volume|Company Short-Term Debt ProPhase Labs
Analysis of all company metrics:ProPhase Labs PRPH
Finished products of ProPhase Labs, Inc.

This indicator tracks obligations with maturities of up to one year, allowing for an assessment of liquidity and the inertia of business liabilities outside of quarterly reporting periods. By analyzing fluctuations in short-term debt, an investor can identify the hidden financial burden of ProPhase Labs, Inc. (PRPH) amid intense pricing pressure from laboratory chains and a general decline in demand for diagnostic tests.

Competitor analysis for ProPhase Labs, Inc.

Agilent - Company Short-Term Debts|DGX: Company Short-Term Debts|Company Short-Term Debt Illumina Corp|Exact Sciences Inc. (EXAS) - Company Short-Term Indebtedness|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts BIO|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt Sotera Health Corp SHC|QDEL: Company Current Liabilities|OPKO Health Corp. - Short-Term Debt|Company Short-Term Debt CDNA (CareDx, Inc.)|MRVI - Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debts|LAB (Standard BioTools Inc) - Short-Term Debt Volume|CTKB: Company Short-Term Debt|Short-Term Debt Volume OSUR|XGN - Company Short-Term Debt|Current Liabilities MDXH (mdxhealth.com)|Company Short-Term Debt Lucid Diagnostics|Prenetics Global Limited - Company Short-Term Loans and Borrowings|IMDX (Insight Molecular) - Company Short-Term Debt|TRIB: Short-Term Debt|Company Short-Term Debt Ainos, Inc. (AIMD)|codiagnostics.com (CODX) - Current Liabilities|HSCS - Company Short-Term Debts|Company Short-Term Loans and Borrowings Biomerica Inc.|Company Short-Term Debts CDIO|Company Short-Term Debts VRAX (Virax Biolabs Corp)|Company Short-Term Debt BJDX|Short-Term Debt Volume aspirawh.com AWH|AXDX (Accelerate Diagnostics, Inc.) - Company Short-Term Debts|CENTOGENE N.V. (CNTG) - Short-Term Debt|Company Current Liabilities enzo.com ENZ|FRES (Fresh2 Group) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Genetic Technologies Ltd|Company Short-Term Debt 23andme.com|Company Short-Term Debts PMD